Cationic porphyrins are reversible proteasome inhibitors.
The aim of this study is to verify if water-soluble porphyrins can be used as proteasome inhibitors. We have found that cationic porphyrins inhibit proteasome peptidase activities much more effectively than the corresponding anionic derivatives. The relevance of electrostatics in driving porphyin-proteasome interactions has been confirmed by the observation that the inhibitory efficiency of the cationic macrocycles decreases with the number of positive substituents. We have also investigated various metalloporphyrins, which differ due to the different propension of the central metal ion toward axial coordination. Our experimental results indicate that the naked cationic porphyrins are the most active in reversibly inhibiting the three main protease activities of the proteasome in the micromolar range. A spectroscopic characterization of porphyrin-proteasome interactions by UV-vis spectra parallels the results of inhibition assays: the higher the inhibitory effect the stronger the spectroscopic variations are. To interpret the action of porphyrins at a molecular level, we have performed calculations evidencing that cationic porphyrins may hinder the access to the canonical proteolytic site on the proteasome β5 subunit. In particular, an inspection of the top-scoring docking modes shows that the tetracationic porphyrin blocks the catalytic pocket, close to the N termini of the β5 proteasome subunit, more efficiently than its anionic counterpart. Proteasome inhibition activity of porphyrins unites their known anticancer properties making them suitable as a scaffold for the design of novel multitargeted molecules.
IBB-CNR, Istituto di Biostrutture e Bioimmagini, UOS di Catania c/o Dipartimento di Scienze Chimiche Viale A. Doria 6 - 95125 Catania.
Anna Maria
AM
Santoro
Maria Cristina
MC
Lo Giudice
Alessandro
A
D'Urso
Rosaria
R
Lauceri
Roberto
R
Purrello
Danilo
D
Milardi
D002412:Cations / Q000494:pharmacology; D004789:Enzyme Activation / Q000187:drug effects; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006367:HeLa Cells; D006801:Humans; D008958:Models, Molecular; D011166:Porphyrins / Q000494:pharmacology*; D061988:Proteasome Inhibitors
D002412:Cations; D004791:Enzyme Inhibitors; D011166:Porphyrins; D061988:Proteasome Inhibitors